Regulation of immune responses by histone deacetylase inhibitors. 2012

Paul V Licciardi, and Tom C Karagiannis
Allergy and Immune Disorders Group, Murdoch Childrens Research Institute, Melbourne, VIC 3052, Australia.

Both genetic and epigenetic factors are important regulators of the immune system. There is an increasing body of evidence attesting to epigenetic modifications that influence the development of distinct innate and adaptive immune response cells. Chromatin remodelling via acetylation, methylation, phosphorylation, and ubiquitination of histone proteins as well as DNA, methylation is epigenetic mechanisms by which immune gene expression can be controlled. In this paper, we will discuss the role of epigenetics in the regulation of host immunity, with particular emphasis on histone deacetylase inhibitors. In particular, the role of HDAC inhibitors as a new class of immunomodulatory therapeutics will also be reviewed.

UI MeSH Term Description Entries

Related Publications

Paul V Licciardi, and Tom C Karagiannis
January 2015, Critical reviews in oncogenesis,
Paul V Licciardi, and Tom C Karagiannis
April 2009, Archives of pharmacal research,
Paul V Licciardi, and Tom C Karagiannis
June 2006, Oncogene,
Paul V Licciardi, and Tom C Karagiannis
October 2019, Neuroscience and biobehavioral reviews,
Paul V Licciardi, and Tom C Karagiannis
October 2003, Journal of neurochemistry,
Paul V Licciardi, and Tom C Karagiannis
April 2013, Human vaccines & immunotherapeutics,
Paul V Licciardi, and Tom C Karagiannis
January 2004, Journal of biochemical and molecular toxicology,
Paul V Licciardi, and Tom C Karagiannis
January 2009, Biochemical and biophysical research communications,
Paul V Licciardi, and Tom C Karagiannis
December 2005, The Journal of biological chemistry,
Paul V Licciardi, and Tom C Karagiannis
August 2010, Bulletin du cancer,
Copied contents to your clipboard!